Drugs, pipelines, approvals —
for every biopharma company

Track FDA approvals, clinical trials, patents, and PDUFA dates.

Try: · · ·

8,245

FDA Drugs

Full approval timeline

Approvals, patents, trials

🏢

Companies

Portfolios & pipelines

🩺

Indications

Diseases & conditions

🎯

Therapeutic Areas

Oncology, CNS, cardio...

Recent FDA Approvals

Top Pharma Companies

Upcoming FDA Decisions

Full calendar

nusinersen (high dose)

Biogen Inc.

2026-04-03

5d away

SPINRAZA (higher dose)

Ionis Pharmaceuticals Inc.

2026-04-03

5d away

RP1 (vusolimogene oderparepvec) + nivolumab

Replimune Group, Inc.

2026-04-10

12d away

Recently Approved Drugs

amivantamab and hyaluronidase-lpuj

Intelligence Dashboards

Deep analytics for pharma research and investing

View All 12

📅

PDUFA Calendar

Upcoming FDA decision dates for drug applications

🚀

Emerging Biotechs

Growth-stage companies with FDA traction

📉

Medicare Exposure

Drugs losing exclusivity 2026-2030

📊

Pipeline Health

Trial activity by phase and company

Built for:

Pharma Consultants Biotech BD VC & Hedge Funds Equity Research Retail Investors

Data Sources: FDA Drugs@FDA, ClinicalTrials.gov, Orange Book, SEC EDGAR.

Data updated: Mar 29, 2026

Drugs, pipelines, approvals —for every biopharma company

Recent FDA Approvals

Top Pharma Companies

Upcoming FDA Decisions

Recently Approved Drugs

Intelligence Dashboards

Drugs, pipelines, approvals —
for every biopharma company